Dr. Andrei Iagaru, MD
Pleasanton, CA
19 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Iagaru, Nuclear Radiologist in Pleasanton, CA?
Dr. Andrei Iagaru, MD is a Nuclear Radiologist, who primarily practices in Pleasanton, CA with 2 additional practice locations. He has been practicing for over 19 years and is board certified by the American Board of Nuclear Medicine. Dr. Iagaru graduated from Universitatea de Medicina si Farmacie Carol Davila and completed his residency at Stanford University Program. Dr. Iagaru is fluent in English, Moldavian, Moldovan, and Romanian, and is currently seeing new patients. Dr. Iagaru’s practice accepts Kaiser Permanente, Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Iagaru’s office at (650) 723-4000.
Where did Dr. Iagaru go to medical school and complete their residency?
Residency: Stanford University Program
Medical School: Carol Davila University of Medicine & Pharmacy | Universitatea de Medicina si Farmacie Carol Davila
Is Dr. Iagaru board certified in Nuclear Radiologist?
Yes, Dr. Andrei Iagaru, MD is board certified by the American Board of Nuclear Medicine
What languages does Dr. Iagaru speak?
Dr. Iagaru and their clinical team can communicate with patients in the following languages:
English
Moldavian
Moldovan
Romanian
What conditions does Dr. Iagaru treat?
As a Nuclear Radiologist, Dr. Iagaru diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Iagaru. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Age-Related Osteoporosis
- Fractures
- Osteoporosis
- Senile Osteoporosis
- Primary Osteoporosis
- Bone Thinning from Aging
ICD-10 Codes:
- M810: Age-related osteoporosis without current pathological fracture
Also known as:
- Multiple Site Bone Density and Structure Disorder
- Bone Density
- Bone Disease
- Widespread Bone Density Disorder
- Generalized Bone Structure Problem
- Multi-site Bone Disorder
ICD-10 Codes:
- M8589: Other specified disorders of bone density and structure, multiple sites
Also known as:
- Prostate Cancer
- Prostate Cancer Treatment (PDQ®)
- Prostatic Carcinoma
- Prostate Gland Cancer
- Malignant Prostate Tumor
ICD-10 Codes:
- C61: Malignant neoplasm of prostate
Also known as:
- Breast Cancer
- Mammary cancer
- Breast carcinoma
- Breast tumor
- Female Breast Cancer
- Malignant Breast Tumor
- Breast Carcinoma
ICD-10 Codes:
- C50912: Malignant neoplasm of unspecified site of left female breast
- C50919: Malignant neoplasm of unspecified site of unspecified female breast
- C50911: Malignant neoplasm of unspecified site of right female breast
Also known as:
- Chest Pain
- Chest discomfort
- Thoracic pain
- Upper body pain
ICD-10 Codes:
- R079: Chest pain, unspecified
Also known as:
- Multiple Myeloma
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
- Active multiple myeloma
- Untreated multiple myeloma
- Plasma cell myeloma
ICD-10 Codes:
- C9000: Multiple myeloma not having achieved remission
Also known as:
- Neuroendocrine Tumor
- Cancer
- Endocrine Disease
- Malignant NET
- Neuroendocrine Cancer
- NET Cancer
ICD-10 Codes:
- C7A8: Other malignant neuroendocrine tumors
Also known as:
- Asymptomatic Menopause
- Menopause
- Menopausal Transition
- Postmenopause
- Change of Life
ICD-10 Codes:
- Z780: Asymptomatic menopausal state
Also known as:
- Lung Cancer
- Right upper lobe lung cancer
- Bronchial cancer
- Malignant neoplasm of lung
- Left Lung Cancer
- Upper Lobe Lung Cancer
- Bronchial Cancer
ICD-10 Codes:
- C3411: Malignant neoplasm of upper lobe, right bronchus or lung
- C3412: Malignant neoplasm of upper lobe, left bronchus or lung
Also known as:
- Secondary Bone Cancer
- Bone Cancer
- Metastatic bone cancer
- Cancer spread to bone
- Bone metastases
ICD-10 Codes:
- C7951: Secondary malignant neoplasm of bone
Also known as:
- Thyroid Cancer
- Thyroid Carcinoma
- Malignant Thyroid Nodule
- Thyroid Gland Cancer
ICD-10 Codes:
- C73: Malignant neoplasm of thyroid gland
Also known as:
- Other Pre-Procedure Examination
- Various pre-op checks
- Miscellaneous pre-surgery exams
- Other pre-treatment assessments
ICD-10 Codes:
- Z01818: Encounter for other preprocedural examination
Also known as:
- Hardening of the Arteries in the Heart without Chest Pain
- Atherosclerosis
- Coronary Artery Disease
- Silent Coronary Artery Disease
- Asymptomatic Atherosclerosis
ICD-10 Codes:
- I2510: Atherosclerotic heart disease of native coronary artery without angina pectoris
Also known as:
- Other Abnormal Findings on Lung Scan
- Unusual Lung Scan Results
- Atypical Lung Imaging
- Nonspecific Lung Abnormality
ICD-10 Codes:
- R918: Other nonspecific abnormal finding of lung field
Also known as:
- Localized Swollen Lymph Nodes
- Enlarged glands in one area
- Local lymphadenopathy
- Swollen glands
ICD-10 Codes:
- R590: Localized enlarged lymph nodes
Also known as:
- Liver Cancer
- Childhood Liver Cancer
- Hepatic Cancer
- Hepatocellular Carcinoma
ICD-10 Codes:
- C220: Liver cell carcinoma
Also known as:
- Shortness of Breath
- Breathing Problems
- Difficulty breathing
- Breathlessness
- Dyspnea
ICD-10 Codes:
- R0602: Shortness of breath
Which procedures does Dr. Iagaru perform as a Nuclear Radiologist?
As a Nuclear Radiologist, procedures performed by a Dr. Andrei Iagaru may include:
- Abdominal Aortic Aneurysm (AAA) Screening
- Abdominal Imaging
- Abdominal Radiology Consultation
- Angiography
- Arthrography
- Barium Swallow
- Bone Biopsy
- Bone Density Measurement / DXA Scan
For detailed information, please contact Dr. Iagaru's office.
Does Dr. Iagaru accept my insurance?
Dr. Iagaru accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Iagaru accept in Pleasanton, CA?
Dr. Iagaru in Pleasanton, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Medicaid
Medicare
Other Provider Networks
Santa Clara Family Health Plan
UnitedHealthcare
View All Insurances
Where is Dr. Iagaru's office located?
Dr. Andrei Iagaru's Primary Practice
5555 W Las Positas Blvd
Pleasanton, CA 94588
(650) 723-4000
Recognitions
Publications
18F-FDG PET/CT in the magement of patients with post-transplant lymphoproliferative disorder.
Nuclear medicine communications, 2014
The Clinical Use of PET/CT in the Evaluation of Melanoma.
Methods in molecular biology (Clifton, N.J.), 2014
Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin
Jourl of nuclear medicine : official publication, Society of Nuclear M, 2013
Root cause alysis of gastroduodel ulceration after yttrium-90 radioembolization.
Cardiovascular and interventiol radiology, 2013
Prognostic Utility of Y-90 Radioembolization Dosimetry Based on Fusion Tc
JOURL OF NUCLEAR MEDICINE, 2013
Combined F-18-fluoride and F-18-FDG PET
EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013
Safety of repeated yttrium-90 radioembolization.
Cardiovascular and interventiol radiology, 2013
Imaging Tumor Angiogenesis: The Road to Clinical Utility
AMERICAN JOURL OF ROENTGENOLOGY, 2013
An Observatiol Study of Circulating Tumor Cells
PLOS ONE, 2013
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F F PET/CT
Clinical nuclear medicine, 2013
Second Sino-American Conference on Nuclear Medicine
JOURL OF NUCLEAR MEDICINE, 2013
Combined F-18-Fluoride and F-18-FDG PET
JOURL OF NUCLEAR MEDICINE, 2013
18F-FDG PET/CT Demonstration of Diffuse Lymphohistiocytic Granulomatous Vasculitis.
Clinical nuclear medicine
Initial investigation of F-18-F PET
EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012
The Impact of Partial Volume Correction in the Evaluation of Solitary Pulmory Nodules by FDG PET
Keu, K., ir, V. S., Mittra, E., Gambhir, S. S., Iagaru, A., 2012
Positron Emission Tomography of Cu-64
MOLECULAR IMAGING AND BIOLOGY, 2012
F-18-FDG PET/CT Demonstration of a Liver Metastasis in a Patient With Papillary Thyroid Cancer
CLINICAL NUCLEAR MEDICINE, 2012
Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012
Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes
INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012
Prospective Evaluation of Tc-99m MDP Scintigraphy, F-18 F PET/CT
MOLECULAR IMAGING AND BIOLOGY, 2012
Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on F-18-FDG PET/CT
EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012
Prospective comparison of combined F-18-FDG
EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012
Response to Intra-Arterial Oncolytic Virotherapy with the Herpes Virus NV1020 Evaluated by [F
HUMAN GENE THERAPY, 2012
Correlation between metabolic tumor volume
RADIOTHERAPY AND ONCOLOGY, 2011
PET/CT Imaging of Thyroid Cancer
CLINICAL NUCLEAR MEDICINE, 2011
Pilot Pharmacokinetic and Dosimetric Studies of F-18-FPPRGD2
RADIOLOGY, 2011
FDG-PET/CT in Cancers of the Head and Neck: What is the Definition of Whole Body Scanning?
MOLECULAR IMAGING AND BIOLOGY, 2011
Thyroid Stunning: Fact or Fiction?
SEMIRS IN NUCLEAR MEDICINE, 2011
Case 166: Metastatic Left Pulmory Artery Sarcoma
RADIOLOGY, 2011
(18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge.
American jourl of nuclear medicine and molecular imaging, 2011
Current concepts and future directions in radioimmunotherapy.
Current drug discovery technologies, 2010
F-18 FDG PET/CT Demonstration of Lymphohistiocytic Meningitis
CLINICAL NUCLEAR MEDICINE, 2010
I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (Zevali (R)) Therapy of Low-Grade Refractory
MOLECULAR IMAGING AND BIOLOGY, 2010
Combined F-18-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? REPLY
JOURL OF NUCLEAR MEDICINE, 2010
Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009
Efficacy of F-18-FDG PET/CT for Breast Cancer
Mittra, E., Quon, A., Gambhir, S. S., Iagaru, A., 2009
Evaluation by F-18-FDG-PET of patients with al squamous cell carcinoma
HELLENIC JOURL OF NUCLEAR MEDICINE, 2009
Tumor Metabolic Phenotypes on F-18 FDG PET REPLY
JOURL OF NUCLEAR MEDICINE, 2009
Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization
JOURL OF VASCULAR AND INTERVENTIOL RADIOLOGY, 2009
Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET
JOURL OF NUCLEAR MEDICINE, 2009
F-18-FDG PET/CT evaluation of patients with ovarian carcinoma
NUCLEAR MEDICINE COMMUNICATIONS, 2008
Y-90-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma
JOURL OF NUCLEAR MEDICINE, 2008
Rhabdomyosarcoma diffusely metastatic to the bone marrow
EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008
F-18-FDG-PET/CT evaluation of response to treatment in lymphoma
HELLENIC JOURL OF NUCLEAR MEDICINE, 2008
Perspectives of molecular imaging and radioimmunotherapy in lymphoma
RADIOLOGIC CLINICS OF NORTH AMERICA, 2008
I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma
MOLECULAR IMAGING AND BIOLOGY, 2008
F-18FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas
CLINICAL NUCLEAR MEDICINE, 2008
Molecular imaging can accelerate anti-angiogenic drug development and testing
TURE CLINICAL PRACTICE ONCOLOGY, 2007
F-18 FDG PET/CT in the magement of thyroid cancer
CLINICAL NUCLEAR MEDICINE, 2007
Advances in metabolic imaging for surgical oncology
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2007
Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET
MOLECULAR IMAGING AND BIOLOGY, 2007
Treatment of thyrotoxicosis
JOURL OF NUCLEAR MEDICINE, 2007
F-18 FDG PET visualization of uriry leak after nephrostomy tube removal
CLINICAL NUCLEAR MEDICINE, 2007
Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET
REVISTA ESPANOLA DE MEDICI NUCLEAR, 2007
2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography
MOLECULAR IMAGING AND BIOLOGY, 2007
F-18FDG PET/CT demonstration of an adrel metastasis in a patient with aplastic thyroid cancer
CLINICAL NUCLEAR MEDICINE, 2007
Breast MRI and F-18 FDG PET/CT in the magement of breast cancer
ANLS OF NUCLEAR MEDICINE, 2007
F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas
CLINICAL NUCLEAR MEDICINE, 2006
F-18-FDG PET and PET/CT for detection of pulmory metastases from musculoskeletal sarcomas
NUCLEAR MEDICINE COMMUNICATIONS, 2006
2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography and positron emission tomography
MOLECULAR IMAGING AND BIOLOGY, 2006
Demonstration of an ectopic mediastil parathyroid adenoma on Tc
JOURL OF NUCLEAR CARDIOLOGY, 2006
PET/CT follow-up in nonossifying fibroma
AMERICAN JOURL OF ROENTGENOLOGY, 2006
F-18FDG PET imaging of uriry bladder oat cell carcinoma with widespread osseous metastases
CLINICAL NUCLEAR MEDICINE, 2006
Merkel cell carcinoma
MOLECULAR IMAGING AND BIOLOGY, 2006
F-18FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation
CLINICAL NUCLEAR MEDICINE, 2006
Demonstration of a right inguil hernia containing uriry bladder diverticulum on whole
EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006
Failed atrial septal defect repair versus pulmory hypertension with right ventricular failure
CLINICAL NUCLEAR MEDICINE, 2005
FDG PET-CT demonstration of Sjogren's sialoadenitis
CLINICAL NUCLEAR MEDICINE, 2005
What is Dr. Iagaru's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Iagaru's National Provider Identifier (NPI) number is 1750404752.
What common questions do patients ask about Dr. Iagaru?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Iagaru
What is Dr. Andrei Iagaru's specialty?
Dr. Iagaru is a Nuclear Radiologist near Pleasanton, CA. A nuclear radiologist has expertise in the analysis of nuclear medicine and utilizes radionuclides and radiolabeled substances for both in vitro and in vivo diagnostics. Additionally, they administer these substances for the treatment of various diseases. Contact Dr. Iagaru to book an appointment today.
Is this Dr. Andrei Iagaru affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Iagaru is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Nuclear Radiologist?
Explore Nuclear Radiologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Andrei Iagaru accepting new patients in Pleasanton, CA?
Yes, Dr. Andrei Iagaru is accepting new patients at this time.
Does Dr. Andrei Iagaru offer online booking?
Please contact Dr. Iagaru's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Andrei Iagaru?
Please contact Dr. Iagaru's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Andrei Iagaru have?
Dr. Andrei Iagaru is certified by the American Board of Nuclear Medicine.
Other Nuclear Radiologist Near Pleasanton, CA
Nuclear Radiologist
Accepting patientsNuclear Radiologist
Accepting patients
Nuclear Radiologist
Accepting patients